| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.00011 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -5.1e-05 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 4.5e-05 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 2.9e-05 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -1.2e-05 | 1 |